A spokesperson for Eli Lilly told Scientific American that the trial used 7 mg and 14 mg doses of oral semaglutide because they were the only approved doses for type 2 diabetes at the time this trial was designed and executed, adding that the results should be interpreted within the context of the doses studied. If approved by the FDA, orforglipron will be available in six doses1 mg, 3 mg, 6 mg, 12 mg, 24 mg and 36 mgthe spokesperson said
Not exactly, but the two are complementary rather than mutually exclusive
Tirzepatide (as Mounjaro) shows superior A1C reduction
Despite this broad therapeutic interest, certain domainsparticularly skeletal muscle biology and neurodegenerationillustrate a recurring translational mismatch between mechanistic signaling effects and clinical functional outcomes
Results vary depending on the condition being treated and individual factors
The thigh is a popular choice because it's easy to visualize, has sufficient subcutaneous tissue, and allows you to inject yourself without assistance